source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-21 07:30:00
| null |
EMERYVILLE, CALIF., SEPT. 21, 2022 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-04 07:30:00
| null |
THE COMPLETION OF REGENERON'S ACQUISITION OF CHECKMATE PHARMACEUTICALS RESULTED IN A $5 MILLION MILESTONE PAYMENT TO KUROS, $2.5 MILLION OF WHICH WAS PAID TO XOMA IN JULY.
|
XOMA REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-20 07:30:00
| null |
EMERYVILLE, CALIF., JUNE 20, 2022 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-02 01:00:00
| null |
AD-HOC ANNOUNCEMENT PURSUANT TO ARTICLE 53 OF THE SIX LISTING RULES
|
KUROS BIOSCIENCES: COMPLETION OF THE ACQUISITION OF CHECKMATE PHARMACEUTICALS BY REGENERON PHARMACEUTICALS TRIGGERS A $5 MILLION MILESTONE PAYMENT
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-05 07:30:00
| null |
EARNED A $2 MILLION MILESTONE FROM REZOLUTE AS IT DOSED THE FINAL PATIENT IN A PHASE 2 OPEN-LABEL STUDY OF RZ358 IN PATIENTS WITH CONGENITAL HYPERINSULINISM IN EARLY 2022. REZOLUTE HAS ANNOUNCED ITS INTENTION TO MOVE RZ358 INTO PHASE 3 CLINICAL DEVELOPMENT.
|
XOMA REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-21 07:30:00
| null |
EMERYVILLE, CALIF., MARCH 21, 2022 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-08 07:30:00
| null |
EARNED $35 MILLION MILESTONE PAYMENT AS NIS793 ENTERED PHASE 3 CLINICAL STUDY IN METASTATIC PANCREATIC CANCER
|
XOMA REPORTS FULL YEAR 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-23 07:30:00
| null |
EMERYVILLE, CALIF., DEC. 23, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-16 07:30:00
| null |
CHIEF EXECUTIVE OFFICER JIM NEAL APPOINTED AS CHAIRMAN; FORMER CHAIRMAN W. DENMAN VAN NESS TO REMAIN LEAD INDEPENDENT DIRECTOR
|
XOMA ANNOUNCES EVOLUTION OF COMPANY LEADERSHIP AND SUCCESSION PLANNING
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-04 07:30:00
| null |
ADDED EIGHT ASSETS TO ITS PORTFOLIO OF POTENTIAL MILESTONE AND ROYALTY ASSETS IN 2021
|
XOMA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-22 07:30:00
| null |
EMERYVILLE, CALIF., SEPT. 22, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA)'S CHIEF EXECUTIVE OFFICER, JIM NEAL, WILL PRESENT AT THE 2021 CANTOR FITZGERALD VIRTUAL GLOBAL HEALTHCARE CONFERENCE ON TUESDAY, SEPTEMBER 28, 2021, AT 10:20 AM PT.
|
XOMA TO PRESENT AT THE 2021 CANTOR FITZGERALD VIRTUAL GLOBAL HEALTHCARE CONFERENCE
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-20 07:30:00
| null |
EMERYVILLE, CALIF., SEPT. 20, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-13 07:30:00
| null |
EMERYVILLE, CALIF., SEPT. 13, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) ANNOUNCED TODAY ITS CHIEF EXECUTIVE OFFICER, JIM NEAL, WILL PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT VIRTUAL CONFERENCE HELD ON SEPTEMBER 13-15, 2021. THE PRESENTATION WILL BE AVAILABLE ON DEMAND BEGINNING SEPTEMBER 13, 2021, AT AT 7:00 AM ET AND CAN BE ACCESSED AT HTTPS://BIT.LY/2X7BWB0. THE PRESENTATION CAN ALSO BE ACCESSED BY VISITING THE INVESTOR RELATIONS SECTION OF THE COMPANY'S WEBSITE AT WWW.XOMA.COM. A REPLAY OF THE PRESENTATION WILL BE AVAILABLE AND ARCHIVED ON THE SITE FOR 90 DAYS AFTER THE EVENT.
|
XOMA TO PRESENT AT H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-10 16:35:00
| null |
EMERYVILLE, CALIF., AUG. 10, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) ANNOUNCED TODAY HEATHER L. FRANKLIN, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BLAZE BIOSCIENCE, INC., HAS JOINED THE COMPANY'S BOARD OF DIRECTORS. MS. FRANKLIN HAS SIGNIFICANT EXPERIENCE IN CORPORATE DEVELOPMENT AND STRATEGY, INCLUDING OVER 10 YEARS OF EXPERIENCE FOUNDING AND LEADING BLAZE AND 10 YEARS OF BUSINESS DEVELOPMENT EXPERIENCE PRIOR TO THAT AT ZYMOGENETICS.
|
XOMA ANNOUNCES HEATHER L. FRANKLIN JOINS ITS BOARD OF DIRECTORS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-05 07:30:00
| null |
ADDED SIX ASSETS TO ITS PORTFOLIO OF POTENTIAL MILESTONE AND ROYALTY ASSETS IN 2021
|
XOMA REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-28 07:30:00
| null |
EMERYVILLE, CALIF., JULY 28, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA), ANNOUNCED TODAY NIS793 IN COMBINATION WITH STANDARD OF CARE CHEMOTHERAPY HAS BEEN GRANTED ORPHAN DRUG DESIGNATION IN PANCREATIC CANCER BY THE U.S. FOOD AND DRUG ADMINISTRATION. NIS793 IS A POTENTIAL FIRST IN CLASS NOVEL ANTIBODY SPECIFIC FOR TRANSFORMING GROWTH FACTOR BETA (TGFΒ). AN ORPHAN DRUG DESIGNATION GRANTS SPECIAL STATUS TO A DRUG THAT TREATS A RARE DISEASE OR CONDITION AND PROVIDES COMPANIES CERTAIN BENEFITS TO ENCOURAGE THE CONTINUED DEVELOPMENT OF MEDICINES THAT BRING NOVEL SOLUTIONS TO PATIENTS WITH THESE SEVERE DISEASES1.
|
U.S. FOOD AND DRUG ADMINISTRATION HAS GRANTED ORPHAN DRUG DESIGNATION TO XOMA'S LICENSED ANTI-TGFΒ ASSET NIS793
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-15 04:17:00
| null |
AD HOC ANNOUNCEMENT PURSUANT TO ARTICLE 53 OF THE SIX LISTING RULES AD HOC ANNOUNCEMENT PURSUANT TO ARTICLE 53 OF THE SIX LISTING RULES
|
KUROS TO RECEIVE $7 MILLION UP FRONT AND POTENTIALLY $166.5 MILLION IN FUTURE REVENUES UNDER A ROYALTY PURCHASE AGREEMENT WITH XOMA RELATED TO KUROS'S LICENSE AGREEMENT WITH CHECKMATE PHARMACEUTICALS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-15 04:00:00
| null |
EMERYVILLE, CALIF., JULY 15, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA), ANNOUNCED TODAY IT HAS ACQUIRED THE ROYALTY INTEREST POSITION KUROS BIOSCIENCES HOLDS IN CHECKMATE PHARMACEUTICALS' VIDUTOLIMOD (CMP-001), AN ADVANCED-GENERATION TOLL-LIKE RECEPTOR 9 AGONIST PACKAGED IN A VIRUS-LIKE PARTICLE, FOR $7.0 MILLION UPFRONT PLUS SALES MILESTONES. VIDUTOLIMOD IS DESIGNED TO TRIGGER THE BODY'S INNATE IMMUNE SYSTEM TO ATTACK TUMORS IN COMBINATION WITH OTHER THERAPIES. THE U.S. FOOD AND DRUG ADMINISTRATION HAS GRANTED FAST TRACK DESIGNATION TO VIDUTOLIMOD FOR THE TREATMENT OF CERTAIN TYPES OF METASTATIC OR UNRESECTABLE MELANOMA AND AN ORPHAN DRUG DESIGNATION FOR STAGES IIB - IV MELANOMA.
|
XOMA ACQUIRES ROYALTY AND MILESTONE INTEREST IN CHECKMATE'S VIDUTOLIMOD (CMP-001) FROM KUROS BIOSCIENCES
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-21 07:30:00
| null |
EMERYVILLE, CALIF., JUNE 21, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED ITS BOARD OF DIRECTORS HAS AUTHORIZED THE FOLLOWING CASH DIVIDENDS TO HOLDERS OF XOMA'S SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK:
|
XOMA DECLARES QUARTERLY PREFERRED STOCK DIVIDENDS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-21 08:00:00
| null |
EMERYVILLE, CALIF., MAY 21, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) RECENTLY LEARNED ITS LICENSEES ARE PRESENTING AT THE UPCOMING 2021 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING, WHICH IS BEING HELD JUNE 4-8, 2021, IN A VIRTUAL SETTING.
|
XOMA LICENSEES TO PRESENT SIGNIFICANT CLINICAL DATA AT 2021 ASCO ANNUAL MEETING
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-06 07:30:00
| null |
XOMA'S PORTFOLIO OF POTENTIAL MILESTONE AND ROYALTY ASSETS NOW HAS GREATER THAN 70 DRUG CANDIDATES. COMPANY ENDED THE FIRST QUARTER OF 2021 WITH $67.8 MILLION IN CASH. THE APRIL 2021 $40 MILLION SERIES B PERPETUAL PREFERRED STOCK OFFERING PAYING 8.375% DIVIDEND INCREASED XOMA'S CASH AND RESTRICTED CASH TO OVER $100 MILLION. BOARD OF DIRECTORS APPROVED FIRST QUARTERLY DIVIDEND PAYMENT FOR XOMAP. ON MAY 3, XOMA ANNOUNCED JANSSEN HAD DOSED THE FIRST PATIENT IN A PHASE 3 CLINICAL STUDY, RESULTING IN A $0.5 MILLION MILESTONE.
|
XOMA REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT OPERATIONAL EVENTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-03 07:30:00
| null |
EMERYVILLE, CALIF., MAY 03, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED IT HAS EARNED A $0.5 MILLION MILESTONE FROM JANSSEN BIOTECH, INC. (JANSSEN), AS A RESULT OF THE FIRST PATIENT DOSED IN A PHASE 3 CLINICAL TRIAL EVALUATING ONE OF JANSSEN'S BIOLOGIC ASSETS.
|
XOMA EARNS MILESTONE FOR FIRST PATIENT DOSED IN PHASE 3 DEVELOPMENT PROGRAM
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-15 09:05:00
| null |
EMERYVILLE, CALIF., APRIL 15, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) TODAY ANNOUNCED ITS PORTFOLIO OF POTENTIAL FUTURE MILESTONE AND ROYALTY ASSETS HAS INCREASED WITH THE ADDITION OF THREE AFFIMED N.V. (NASDAQ: AFMD) INNATE CELL ENGAGER (ICE®) PROGRAMS FOR WHICH XOMA COULD RECEIVE FUTURE ECONOMICS. IN 2006, AFFIMED LICENSED CERTAIN XOMA TECHNOLOGIES TO FURTHER ITS RESEARCH AND DISCOVERY EFFORTS.
|
XOMA'S ROYALTY PORTFOLIO GROWS WITH ADDITION OF THREE ROYALTY ASSETS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-12 07:30:00
| null |
RAISED AGGREGATE GROSS PROCEEDS OF $40 MILLION
|
XOMA ANNOUNCES CLOSING OF DEPOSITARY SHARES OFFERING AND EXERCISE OF UNDERWRITERS' OPTION
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 19:02:00
| null |
DEPOSITARY SHARES REPRESENT AN INTEREST IN 8.375% SERIES B CUMULATIVE PERPETUAL PREFERRED STOCK DEPOSITARY SHARES REPRESENT AN INTEREST IN 8.375% SERIES B CUMULATIVE PERPETUAL PREFERRED STOCK
|
XOMA PRICES $35 MILLION OFFERING OF DEPOSITARY SHARES
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-05 16:05:00
| null |
EMERYVILLE, CALIF., APRIL 05, 2021 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED IT HAS COMMENCED AN UNDERWRITTEN REGISTERED PUBLIC OFFERING OF DEPOSITARY SHARES, EACH REPRESENTING 1/1000TH FRACTIONAL INTEREST IN A SHARE OF THE COMPANY'S SERIES B CUMULATIVE PERPETUAL PREFERRED STOCK, WITH LIQUIDATION PREFERENCE OF $25.00 PER DEPOSITARY SHARE, SUBJECT TO MARKET AND CERTAIN OTHER CONDITIONS. THE COMPANY EXPECTS TO GRANT THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE ADDITIONAL DEPOSITARY SHARES IN CONNECTION WITH THE OFFERING.
|
XOMA ANNOUNCES OFFERING OF DEPOSITARY SHARES AND SERIES B CUMULATIVE PERPETUAL PREFERRED STOCK
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-10 07:30:00
| null |
RECOGNIZED REVENUE OF $29.4 MILLION SIX ASSETS IN THE COMPANY'S MILESTONE AND ROYALTY PORTFOLIO ADVANCED TO PHASE 2 CLINICAL DEVELOPMENT COMPLETED $24.6 MILLION SERIES A PERPETUAL PREFERRED STOCK OFFERING PAYING A 8.625% DIVIDEND ENDED 2020 WITH $84.2 MILLION IN CASH
|
XOMA REPORTS FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND OPERATING HIGHLIGHTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-21 17:00:00
| null |
EMERYVILLE, CALIF., DEC. 21, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED THE CLOSING OF ITS PREVIOUSLY ANNOUNCED UNDERWRITTEN REGISTERED PUBLIC OFFERING OF 984,000 SHARES, WHICH INCLUDES THE UNDERWRITERS OPTION TO PURCHASE ADDITIONAL 104,000 SHARES OF ITS 8.625% SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK, WITH LIQUIDATION PREFERENCE OF $25.00 PER SHARE (THE “PREFERRED STOCK”), AT AN INITIAL PUBLIC OFFERING PRICE OF $25.00 PER SHARE. THE OFFERING RESULTED IN NET PROCEEDS OF APPROXIMATELY $23.4 MILLION AFTER DEDUCTING UNDERWRITING DISCOUNTS AND COMMISSIONS, BUT BEFORE DEDUCTING EXPENSES AND THE STRUCTURING FEE. THE COMPANY EXPECTS TO USE THE NET PROCEEDS OF THIS OFFERING TO FUND THE SEGREGATED DIVIDEND ACCOUNT AND THE REMAINING NET PROCEEDS FOR GENERAL CORPORATE PURPOSES, INCLUDING FUNDING FUTURE ACQUISITIONS OF MILESTONE AND ROYALTY RIGHTS ASSOCIATED WITH DRUG DEVELOPMENT PROGRAMS WITH THIRD-PARTY FUNDING. SHARES OF THE PREFERRED STOCK ARE TRADING ON NASDAQ UNDER THE SYMBOL “XOMAP”.
|
XOMA ANNOUNCES EXERCISE OF GREEN SHOE OPTION AND CLOSES PREFERRED STOCK OFFERING
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-10 18:22:00
| null |
EMERYVILLE, CALIF., DEC. 10, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED THE PRICING OF ITS UNDERWRITTEN REGISTERED PUBLIC OFFERING OF 880,000 SHARES OF 8.625% SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK, WITH LIQUIDATION PREFERENCE OF $25.00 PER SHARE (THE “PREFERRED STOCK”) AT AN INITIAL PUBLIC OFFERING PRICE OF $25.00 PER SHARE, RAISING GROSS PROCEEDS OF $22.0 MILLION BEFORE DEDUCTING UNDERWRITING DISCOUNTS, THE STRUCTURING FEE AND OTHER ESTIMATED OFFERING EXPENSES.
|
XOMA PRICES $22 MILLION OFFERING OF SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-10 07:52:00
| null |
EMERYVILLE, CALIF., DEC. 10, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED IT HAS COMMENCED AN UNDERWRITTEN REGISTERED PUBLIC OFFERING OF SHARES OF ITS SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK, WITH LIQUIDATION PREFERENCE OF $25.00 PER SHARE (THE “PREFERRED STOCK”). THE COMPANY EXPECTS TO GRANT THE UNDERWRITERS A 30-DAY OPTION TO PURCHASE ADDITIONAL SHARES OF THE PREFERRED STOCK IN CONNECTION WITH THE OFFERING.
|
XOMA ANNOUNCES OFFERING OF SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-16 07:30:00
| null |
EMERYVILLE, CALIF., NOV. 16, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED IT HAS EARNED A $2 MILLION MILESTONE PAYMENT FROM TAKEDA PHARMACEUTICAL COMPANY LIMITED AS THE FIRST PATIENT HAS BEEN DOSED IN ITS PHASE 2 STUDY TO EVALUATE SAFETY, TOLERABILITY, AND EFFICACY OF MEZAGITAMAB (TAK-079) IN PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS (MG). IN 2006, XOMA AND TAKEDA ENTERED INTO A COLLABORATION AGREEMENT TO IDENTIFY POTENTIAL THERAPEUTIC ANTIBODIES THAT TAKEDA WOULD ADVANCE INTO CLINICAL DEVELOPMENT. MEZAGITAMAB IS AN ANTI-CD38 ANTIBODY THAT RESULTED FROM THE COMPANIES' COLLABORATION.
|
XOMA EARNS $2 MILLION MILESTONE FROM TAKEDA AS MEZAGITAMAB ADVANCES INTO PHASE 2 DEVELOPMENT
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-11 07:30:00
| null |
EMERYVILLE, CALIF., NOV. 11, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) (“XOMA” OR THE “COMPANY”) TODAY ANNOUNCED IT HAS EARNED A $1 MILLION MILESTONE PAYMENT FROM AGENUS INC. (NASDAQ: AGEN) RELATED TO MERCK'S ADVANCEMENT OF MK-4830 INTO A PHASE 2 STUDY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PREVIOUSLY TREATED WITH ANTI-PROGRAMMED CELL DEATH RECEPTOR LIGAND 1 (PD-L1) THERAPY. MK-4830 IS PART OF XOMA'S FIRST TRANSACTION UNDER ITS ROYALTY AND MILESTONE AGGREGATOR BUSINESS MODEL IN WHICH THE COMPANY ACQUIRED A ROYALTY INTEREST IN SEVEN MILESTONE AND ROYALTY-BEARING LICENSES AGENUS HELD WITH MERCK AND INCYTE FOR $15 MILLION.
|
XOMA EARNS FIRST MILESTONE PAYMENT FROM 2018 ROYALTY PURCHASE AGREEMENT
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-05 07:30:00
| null |
COMPANY RECENTLY EARNED A $ 25 MILLION MILESTONE PAYMENT AS NIS793 ADVANCED TO PHASE 2 DEVELOPMENT IN ADVANCED PANCREATIC CANCER AN U NDISCLOSED PARTNER ENTERED PHASE 2 DEVELOPMENT, TRIGGERING A $0.5 MILLION MILESTONE REZOLUTE'S FINANCING RESULTED IN ACCELERATED $1.4 MILLION PAYMENT TWO PARTNERS PRESENTED EARLY STAGE DATA AT SCIENTIFIC CONFERENCES ACQUIRED ROYALTY INTEREST IN FOUR LYSOSOMAL STORAGE DISORDER ENZYMES BEING DEVELOPED BY CHIESI GROUP ADDITIONAL PARTNER-FUNDED ASSETS ADVANCED TO NEXT STAGES OF CLINICAL DEVELOPMENT, EVEN THOUGH CLINICAL TRIAL ENROLLMENT ACROSS THE INDUSTRY REMAINS CHALLENGING DUE TO THE COVID-19 PANDEMIC
|
XOMA HIGHLIGHTS RECENT ROYALTY ASSET PORTFOLIO DEVELOPMENTS AND REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-03 07:30:00
| null |
EMERYVILLE, CALIF., NOV. 03, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA), ANNOUNCED TODAY IT HAS ACQUIRED THE RIGHTS TO FUTURE MILESTONE AND ROYALTY REVENUE DUE TO BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), ASSOCIATED WITH THE ADVANCEMENT OF THE ENZYMES BEING INVESTIGATED AS POTENTIAL TREATMENTS FOR FOUR DIFFERENT LYSOSOMAL STORAGE DISORDERS (LSD) UNDER BIOASIS' STRATEGIC ALLIANCE WITH CHIESI GROUP.
|
XOMA ACQUIRES ROYALTY INTEREST IN FOUR LYSOSOMAL STORAGE DISORDER ENZYMES BEING DEVELOPED UNDER THE CHIESI GROUP–BIOASIS STRATEGIC ALLIANCE
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-28 07:30:00
| null |
EMERYVILLE, CALIF., OCT. 28, 2020 (GLOBE NEWSWIRE) -- XOMA CORPORATION (NASDAQ: XOMA) ANNOUNCED TODAY NIS793, AN ANTI-TGFΒ MONOCLONAL ANTIBODY LICENSED FROM XOMA, HAS ADVANCED TO THE PHASE 2 DEVELOPMENT STAGE, TRIGGERING A $25 MILLION MILESTONE PAYMENT FROM NOVARTIS. THE PHASE 2 TRIAL (NCT04390763) IS DESIGNED TO ASSESS THE EFFICACY AND SAFETY OF NIS793 IN FIRST-LINE METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC).
|
XOMA EARNS $25 MILLION MILESTONE PAYMENT AS ANTI-TGFΒ ANTIBODY ENTERS PHASE 2 CLINICAL STUDY IN METASTATIC PANCREATIC CANCER
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-06 19:30:00
| null |
XOMA REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS.Q2 REVENUE $400,000 VERSUS $1.0 MILLION.Q2 REVENUE ESTIMATE $2.3 MILLION -- REFINITIV IBES DATA.QTRLY LOSS PER SHARE $0.33.
|
XOMA REPORTS Q2 REVENUE OF $400,000
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-05 09:30:00
| null |
XOMA REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES COVID-19 BUSINESS UPDATE.Q1 REVENUE $800,000 VERSUS $8.1 MILLION.Q1 REVENUE ESTIMATE $3.4 MILLION -- REFINITIV IBES DATA.QTRLY LOSS PER SHARE $0.49.
|
XOMA REPORTS QTRLY LOSS PER SHARE OF $0.49
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-23 09:30:00
| null |
MARK N. LAMPERT REPORTS A 27.1% STAKE IN XOMA CORP AS OF DECEMBER 18, 2019 - SEC FILING.MARK N. LAMPERT PREVIOUSLY HELD A 20.4% STAKE IN XOMA CORP AS OF DECEMBER 18, 2018 - SEC FILING.
|
MARK N. LAMPERT REPORTS A 27.1% STAKE IN XOMA CORP AS OF DEC 18, 2019
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-18 22:30:00
| null |
XOMA CORPORATION HAS FILED A FOLLOW-ON EQUITY OFFERING IN THE AMOUNT OF $22 MILLION.
SECURITY NAME: COMMON STOCK
SECURITY TYPE: COMMON STOCK
SECURITIES OFFERED: 1,000,000
PRICE\RANGE: $22
TRANSACTION FEATURES: RIGHTS OFFERING
|
XOMA CORPORATION HAS FILED A FOLLOW-ON EQUITY OFFERING IN THE AMOUNT OF $22 MILLION.
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-17 22:30:00
| null |
REZOLUTE, INC. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $1.021778 MILLION.
SECURITY NAME: COMMON STOCK
SECURITIES OFFERED: 9,246,857
|
REZOLUTE, INC. HAS FILED A SHELF REGISTRATION IN THE AMOUNT OF $1.021778 MILLION.
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-05 11:30:00
| null |
XOMA REPORTS THIRD QUARTER 2019 ROYALTY ASSET PORTFOLIO HIGHLIGHTS AND FINANCIAL RESULTS.Q3 REVENUE $8.9 MILLION VERSUS $900,000.Q3 REVENUE ESTIMATE $1.5 MILLION -- REFINITIV IBES DATA.QTRLY EPS $0.20.
|
XOMA REPORTS THIRD QUARTER 2019 ROYALTY ASSET PORTFOLIO HIGHLIGHTS AND FINANCIAL RESULTS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-04 22:30:00
| null |
XOMA CORPORATION ANNOUNCED EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019. FOR THE THIRD QUARTER, THE COMPANY ANNOUNCED TOTAL REVENUE WAS USD 8.855 MILLION COMPARED TO USD 896,000 A YEAR AGO. OPERATING INCOME WAS USD 2.891 MILLION COMPARED TO OPERATING LOSS OF USD 5.307 MILLION A YEAR AGO. NET INCOME WAS USD 3.178 MILLION COMPARED TO NET LOSS OF USD 4.578 MILLION A YEAR AGO. BASIC EARNINGS PER SHARE WAS USD 0.21 COMPARED TO BASIC LOSS PER SHARE OF USD 0.55 A YEAR AGO. DILUTED EARNINGS PER SHARE WAS USD 0.2 COMPARED TO DILUTED LOSS PER SHARE OF USD 0.55 A YEAR AGO. FOR THE NINE MONTHS, TOTAL REVENUE WAS USD 17.948 MILLION COMPARED TO USD 3.614 MILLION A YEAR AGO. OPERATING INCOME WAS USD 116,000 COMPARED TO OPERATING LOSS OF USD 13.435 MILLION A YEAR AGO. NET INCOME WAS USD 2.339 MILLION COMPARED TO NET LOSS OF USD 10.331 MILLION A YEAR AGO. BASIC EARNINGS PER SHARE WAS USD 0.16 COMPARED TO BASIC LOSS PER SHARE OF USD 1.24 A YEAR AGO. DILUTED EARNINGS PER SHARE WAS USD 0.15 COMPARED TO DILUTED LOSS PER SHARE OF USD 1.24 A YEAR AGO.
|
XOMA CORPORATION REPORTS EARNINGS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2019
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-26 18:30:00
| null |
XOMA ACQUIRES ROYALTY INTEREST POSITION IN SIX CLINICAL-STAGE ASSETS.XOMA CORP - ACQUIRED A ROYALTY INTEREST IN SIX CLINICAL-STAGE ASSETS TARGETING ADENOSINE PATHWAY FOR $10.0 MILLION FROM PALOBIOFARMA S.L..XOMA CORP - WILL RECEIVE LOW SINGLE-DIGIT ROYALTIES ON FUTURE SALES OF THESE SIX ADENOSINE RECEPTOR ASSETS.XOMA - CO HAS ACQUIRED A ROYALTY INTEREST IN NIR178, THAT IS BEING DEVELOPED BY NOVARTIS AS A NOVEL CHECKPOINT INHIBITOR FOR TREATMENT OF SOLID TUMORS.
|
XOMA ACQUIRES ROYALTY INTEREST POSITION IN SIX CLINICAL-STAGE ASSETS
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-09-25 22:30:00
| null |
XOMA CORPORATION PRESENTS AT CANTOR FITZGERALD ANNUAL GLOBAL HEALTHCARE CONFERENCE, OCT-02-2019 07:45 AM. VENUE: INTERCONTINENTAL NEW YORK BARCLAY, NEW YORK, NEW YORK, UNITED STATES. SPEAKERS: JAMES R. NEAL, CEO & DIRECTOR.
|
XOMA CORPORATION PRESENTS AT CANTOR FITZGERALD ANNUAL GLOBAL HEALTHCARE CONFERENCE, OCT-02-2019 07:45 AM
|
XOMA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-04 11:00:00
| null |
NEW YORK--(BUSINESS WIRE)--ATTORNEY ADVERTISING-- BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST PRECIGEN, INC. F/K/A INTREXON CORPORATION (“PRECIGEN” OR THE "COMPANY") (NASDAQ: PGEN) (NASDAQ: XON) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF SHAREHOLDERS WHO PURCHASED OR OTHERWISE ACQUIRED PRECIGEN SECURITIES BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"). SUCH INVESTORS ARE ENCOURAGED TO JOIN THIS CASE BY
|
PGEN FINAL DEADLINE: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES PRECIGEN, INC. F/K/A INTREXON CORPORATION SHAREHOLDERS OF CLASS ACTION AND LEAD PLAINTIFF DEADLINE: DECEMBER 4, 2020
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-03 17:29:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 3, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN) (NASDAQ: XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 4, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION COMMENCED BY THE FIRM. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN F/K/A INTREXON...
|
PGEN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM; ENCOURAGE INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-02 11:00:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 2, 2020) - BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES INVESTORS THAT A CLASS ACTION LAWSUIT HAS BEEN FILED AGAINST PRECIGEN, INC. F/K/A INTREXON CORPORATION ("PRECIGEN" OR THE "COMPANY") (NASDAQ: PGEN) (NASDAQ: XON) AND CERTAIN OF ITS OFFICERS, ON BEHALF OF SHAREHOLDERS WHO PURCHASED OR OTHERWISE ACQUIRED PRECIGEN SECURITIES BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"). SUCH INVESTORS ARE ENCOURAGED TO JOIN THIS CASE...
|
PGEN UPCOMING DEADLINE: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC NOTIFIES PRECIGEN, INC. F/K/A INTREXON CORPORATION SHAREHOLDERS OF CLASS ACTION AND LEAD PLAINTIFF DEADLINE: DECEMBER 4, 2020
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-27 17:00:00
| null |
NEW YORK, NOV. 27, 2020 (GLOBE NEWSWIRE) -- PAWAR LAW GROUP ANNOUNCES THAT A CLASS ACTION LAWSUIT HAS BEEN FILED ON BEHALF OF SHAREHOLDERS WHO PURCHASED SHARES OF PRECIGEN, INC. F/K/A (NASDAQ: PGEN, XON) FROM MAY 10, 2017 THROUGH SEPTEMBER 25, 2020, INCLUSIVE (THE “CLASS PERIOD”). THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS UNDER THE FEDERAL SECURITIES LAWS.
|
UPCOMING DEADLINE: PAWAR LAW GROUP ANNOUNCES A SECURITIES CLASS ACTION LAWSUIT AGAINST PRECIGEN, INC. F/K/A INTREXON-- PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-27 10:11:00
| null |
NEW YORK, NOV. 27, 2020 /PRNEWSWIRE/ -- BERNSTEIN LIEBHARD, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT THAT HAS BEEN FILED ON BEHALF OF INVESTORS THAT PURCHASED OR ACQUIRED THE...
|
PGEN INVESTOR DEADLINE: BERNSTEIN LIEBHARD REMINDS INVESTORS OF THE DEADLINE TO FILE A LEAD PLAINTIFF MOTION IN A SECURITIES CLASS ACTION LAWSUIT AGAINST PRECIGEN INC., F/K/A INTREXON CORPORATION
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-23 17:04:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 23, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN) (NASDAQ: XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 4, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION COMMENCED BY THE FIRM. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN F/K/A INTREXON...
|
ROSEN, A TOP RANKED LAW FIRM, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM - PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 19:04:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 13, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN) (NASDAQ: XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 4, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION COMMENCED BY THE FIRM. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN F/K/A INTREXON INVESTORS...
|
ROSEN, A LEADING LAW FIRM, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-04 17:48:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - NOVEMBER 4, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN) (NASDAQ: XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 4, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION COMMENCED BY THE FIRM. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN F/K/A INTREXON INVESTORS...
|
ROSEN, A LEADING LAW FIRM, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-29 19:05:00
| null |
NEW YORK, OCT. 29, 2020 /PRNEWSWIRE/ -- ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN, XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT...
|
ROSEN, A LEADING LAW FIRM, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM; ENCOURAGES INVESTORS WITH LOSSES IN EXCESS OF $100K TO CONTACT FIRM - PGE
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-28 22:02:00
| null |
NEW YORK, NEW YORK--(NEWSFILE CORP. - OCTOBER 28, 2020) - ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF THE SECURITIES OF PRECIGEN, INC. F/K/A INTREXON CORPORATION (NASDAQ: PGEN) (NASDAQ: XON) BETWEEN MAY 10, 2017 AND SEPTEMBER 25, 2020, INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 4, 2020 LEAD PLAINTIFF DEADLINE IN THE SECURITIES CLASS ACTION COMMENCED BY THE FIRM. THE LAWSUIT SEEKS TO RECOVER DAMAGES FOR PRECIGEN F/K/A INTREXON INVESTORS...
|
ROSEN, RESPECTED INVESTOR COUNSEL, REMINDS PRECIGEN, INC. F/K/A INTREXON CORPORATION INVESTORS OF IMPORTANT DECEMBER 4 DEADLINE IN FIRST FILED SECURITIES CLASS ACTION COMMENCED BY THE FIRM - PGEN, XON
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-02 14:30:00
| null |
EFFECTIVE IMMEDIATELY, APPOINTED HELEN SABZEVARI, AS PRESIDENT AND CEO.WILL REFOCUS COMPANY ON HEALTHCARE AND CHANGE ITS NAME TO PRECIGEN, INC.TO SELL CERTAIN OF ITS OTHER NON-HEALTHCARE ASSETS TO THIRD SECURITY, LLC, FOR $53 MILLION IN CASH.THIRD SECURITY HAS AGREED TO PURCHASE FROM CO $35 MILLION OF SHARES OF CO'S COMMON STOCK.TWO NON-HEALTHCARE BUSINESSES WILL REMAIN WITH CO: MBP TITAN LLC, AND TRANS OVA GENETICS.WILL CONTINUE TO EVALUATE STRATEGIC AND OPERATIONAL OPTIONS FOR MBP TITAN LLC, AND TRANS OVA GENETICS.TO SELL ITS INTEREST IN ENVIROFLIGHT, LLC, TO DARLING INGREDIENTS, INC. FOR $12.2 MILLION IN CASH.CO HAS ABILITY TO TERMINATE AGREEMENT WITH THIRD SECURITY TO ACCEPT A HIGHER BID.
|
INTREXON SAYS EFFECTIVE IMMEDIATELY, APPOINTED HELEN SABZEVARI, AS PRESIDENT AND CEO
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-12 10:30:00
| null |
INTREXON REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 REVENUE $23 MILLION.Q3 REVENUE ESTIMATE $33 MILLION -- REFINITIV IBES DATA.TIGHTENED FOCUS ON HEALTHCARE AND ON TRACK TO MEET YEAREND TRANSACTIONAL AND CASH GOALS.CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS TOTALED $89.7 MILLION AT SEPTEMBER 30.QTRLY LOSS PER SHARE $0.35.Q3 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA.
|
INTREXON REPORTS Q3 REVENUE OF $23 MLN
|
XON
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-12 09:28:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--DESKTOP METAL, INC. (NYSE: DM) (“DESKTOP METAL”) TODAY ANNOUNCED IT HAS SUCCESSFULLY COMPLETED ITS ACQUISITION OF THE EXONE COMPANY (NASDAQ: XONE) (“EXONE”) FOLLOWING APPROVAL BY A MAJORITY OF EXONE'S SHAREHOLDERS. THE ACQUISITION REINFORCES DESKTOP METAL'S LEADERSHIP IN ADDITIVE MANUFACTURING (AM) FOR MASS PRODUCTION. EXONE EXTENDS DESKTOP METAL'S PRODUCT PLATFORMS WITH COMPLEMENTARY SOLUTIONS TO CREATE AN UNPARALLELED AM PORTFOLIO THAT OFFERS INDUSTRY-L
|
DESKTOP METAL COMPLETES ACQUISITION OF EXONE, CEMENTING ITS LEADERSHIP IN ADDITIVE MANUFACTURING FOR MASS PRODUCTION
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-11 08:31:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE SCHUNK GROUP WILL OFFER SERIAL PRODUCTION OF BINDER JET 3D PRINTED METAL PARTS TO THE AUTOMOTIVE, AEROSPACE, MEDICAL AND OTHER INDUSTRIES.
|
EXONE ANNOUNCES SCHUNK HAS PURCHASED AN X1 25PRO® FOR THE PRODUCTION OF BINDER JET 3D PRINTED METAL PARTS AS A SERVICE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-11 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE FIRST OF A SERIES OF 3D PRINTED ULTRAHIGH-RELIEF SILVER COINS FEATURING A CROWNED LION WILL BE ON DISPLAY AT FORMNEXT 2021 IN FRANKFURT, GERMANY.
|
EXONE ANNOUNCES THE PRESSBURG MINT OF SLOVAKIA HAS PURCHASED TWO X1 160PRO™ METAL 3D PRINTERS TO PRODUCE SILVER INVESTMENT COINS AND HIGH-PERFORMANCE STEEL PARTS FOR WIDE RANGE OF INDUSTRIES
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 16:45:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY ANNOUNCED THAT ITS STOCKHOLDERS VOTED TO APPROVE THE ACQUISITION OF EXONE BY DESKTOP METAL, INC. THE FINAL VOTING RESULTS WILL BE FILED IN A FORM 8-K WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION. PURSUANT TO THE MERGER AGREEMENT, THE TRANSACTION IS EXPECTED TO CLOSE WITHIN THREE BUSINESS DAYS AFTER TODAY, SUBJECT TO CUSTO
|
EXONE SHAREHOLDERS APPROVE ACQUISITION BY DESKTOP METAL
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 08:32:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--SUCCESSFUL BINDER JET 3D PRINTING OF GOLD AND SILVER PRECIOUS METALS OPENS DOOR TO REVOLUTIONARY DESIGNS FOR THE LUXURY GOODS INDUSTRY AT HIGH VOLUMES
|
EXONE ANNOUNCES SWISS STARTUP NEOSHAPES HAS PURCHASED THE FIRST OF SEVERAL INNOVENTPRO™ SYSTEMS TO 3D PRINT GOLD
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 08:31:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE X1 POWDER GRIP™ IS PART OF A COMPREHENSIVE NEW POWDER MANAGEMENT SYSTEM FOR THE INNOVENTPRO METAL 3D PRINTER, BEING SHOWN AT FORMNEXT 2021.
|
EXONE UNVEILS THE X1 POWDER GRIP™ TO SIMPLIFY THE MANAGEMENT OF MIM POWDERS IN THE ALL-NEW INNOVENTPRO™ METAL 3D PRINTER
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-11-09 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE GLOBAL PREMIERE OF THE PRODUCTION MODEL OF THE INNOVENTPRO™ METAL 3D PRINTER IS SLATED FOR FORMNEXT 2021, NOV. 16-19 IN FRANKFURT, GERMANY.
|
EXONE ANNOUNCES SIEMENS AS INAUGURAL CUSTOMER FOR ALL-NEW INNOVENTPRO™ ENTRY-LEVEL METAL BINDER JET 3D PRINTER
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-20 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--BASED ON THE SUCCESS OF EXONE'S PATENTED BINDER JETTING TECHNOLOGY, EXONE NOW OPEN TO 3D PRINTING DEVELOPMENT PROJECTS WITH VIRTUALLY ANY POWDER TYPE.
|
EXONE SHOWCASES ABILITY TO 3D PRINT VIRTUALLY ANY POWDER MATERIAL IN NEW CORPORATE VIDEO, “LET'S MAKE IT RIGHT”
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-10-08 18:58:00
| null |
NEW YORK, OCT. 8, 2021 /PRNEWSWIRE/ -- IF YOU OWN SHARES IN ANY OF THE COMPANIES LISTED ABOVE AND WOULD LIKE TO DISCUSS OUR INVESTIGATIONS OR HAVE ANY QUESTIONS CONCERNING THIS NOTICE OR YOUR RIGHTS OR INTERESTS, PLEASE CONTACT: JOSHUA RUBIN, ESQ. WEISSLAW LLP305 BROADWAY, 7TH FLOOR NEW YORK, NY 10007 (212) 682-3025 (888) 593-4771 STOCKINFO@WEISSLAWLLP.COM GREAT WESTERN BANCORP, INC. (NYSE: GWB) WEISSLAW LLP IS INVESTIGATING POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW BY THE BOARD OF DIRECTORS OF GREAT WESTERN BANCORP, INC. (NYSE: GWB) IN CONNECTION WITH THE PROPOSED ACQUISITION OF THE COMPANY BY FIRST INTERSTATE BANCSYSTEM, INC. ("FIRST INTERSTATE").
|
SHAREHOLDER ALERT: WEISSLAW LLP REMINDS GWB, NLOK, SIC, AND XONE SHAREHOLDERS ABOUT ITS ONGOING INVESTIGATIONS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-22 08:30:00
| null |
NORTH HUNTINGDON, PA. & JANESVILLE, WIS.--(BUSINESS WIRE)--SSI SINTERED SPECIALTIES, AN INTERNATIONAL SUPPLIER OF HIGH-PERFORMANCE METAL PRODUCTS, HAS PURCHASED TWO BINDER JET METAL 3D PRINTERS FROM EXONE.
|
EXONE AND SSI PARTNER TO DRIVE VOLUME PRODUCTION WITH METAL BINDER JETTING
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-13 14:59:00
| null |
NEW YORK, SEPT. 13, 2021 /PRNEWSWIRE/ -- JUAN MONTEVERDE , FOUNDER AND MANAGING PARTNER AT MONTEVERDE & ASSOCIATES PC, A NATIONAL SECURITIES FIRM RATED TOP 50 IN THE 2018-2020 ISS SECURITIES CLASS ACTION SERVICES REPORT AND HEADQUARTERED AT THE EMPIRE STATE BUILDING IN NEW YORK CITY, IS INVESTIGATING THE EXONE COMPANY ("XONE" OR THE "COMPANY") (XONE) RELATING TO ITS PROPOSED ACQUISITION BY DESKTOP METAL, INC. UNDER THE TERMS OF THE AGREEMENT, XONE SHAREHOLDERS WILL RECEIVE $8.50 IN CASH AND $17.00 WORTH OF SHARES OF DESKTOP METAL PER SHARE THEY OWN.
|
SHAREHOLDER ALERT: MONTEVERDE & ASSOCIATES PC ANNOUNCES AN INVESTIGATION OF THE EXONE COMPANY - XONE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-07 08:31:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--NEW PORTFOLIO OF 3D PRINTED TOOLING OPTIONS WAS CREATED FOR MANUFACTURERS LOOKING FOR FAST AND LOCAL SOLUTIONS IN RESPONSE TO SUPPLY CHAIN CHALLENGES.
|
EXONE LAUNCHES WORLD'S BROADEST PORTFOLIO OF INDUSTRIAL- GRADE 3D PRINTED TOOLING SOLUTIONS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-07 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--CELWISE CREATES ALL-NEW WATER-RESISTANT MATERIAL AND PRODUCTS THAT ARE RECYCLABLE, RENEWABLE AND BIODEGRADABLE WITH EXONE 3D PRINTED TOOLS.
|
CELWISE AB USES EXONE 3D PRINTED TOOLING TO TRANSFORM WOOD FIBER INTO INNOVATIVE, SINGLE-USE PLASTIC REPLACEMENT
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-01 08:30:00
| null |
BREMEN, GERMANY & NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE NEWS FOLLOWS THE SUCCESS OF CLEANFUSE™ METAL BINDER, A CLEAN-BURNING BINDER FOR OPTIMAL 3D PRINTING OF STAINLESS STEELS AND PREMIUM METALS.
|
EXONE AND FRAUNHOFER IFAM DEEPEN PARTNERSHIP ON METAL BINDER, MATERIALS DEVELOPMENT
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-31 16:17:00
| null |
NEW YORK , AUG. 31, 2021 /PRNEWSWIRE/ -- MOORE KUEHN, PLLC, A LAW FIRM FOCUSING IN SECURITIES LITIGATION LOCATED ON WALL STREET IN DOWNTOWN NEW YORK CITY, IS INVESTIGATING POTENTIAL CLAIMS CONCERNING WHETHER THE FOLLOWING PROPOSED MERGERS ARE FAIR TO SHAREHOLDERS. MOORE KUEHN MAY SEEK INCREASED CONSIDERATION, ADDITIONAL DISCLOSURES, OR OTHER RELIEF ON BEHALF OF THE SHAREHOLDERS OF THESE COMPANIES: VINE ENERGY INC. (NYSE: VEI) VINE ENERGY HAS AGREED TO MERGE WITH CHESAPEAKE ENERGY.
|
MOORE KUEHN ENCOURAGES VEI, IEC, XONE, AND ASAX INVESTORS TO CONTACT LAW FIRM
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-13 18:32:00
| null |
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND THE LAW FIRM OF KAHN SWICK & FOTI, LLC (“KSF”) ARE INVESTIGATING THE PROPOSED SALE OF THE EXONE COMPANY (NASDAQGS: XONE) TO DESKTOP METAL, INC. (NYSE: DM). UNDER THE TERMS OF THE PROPOSED TRANSACTION, SHAREHOLDERS OF EXONE WILL RECEIVE ONLY $8.50 IN CASH AND $17.00 IN SHARES OF DESKTOP FOR EACH SHARE OF EXONE THAT THEY OWN, SUBJECT TO CERTAIN ADJUSTMENTS. KSF IS SEEKING TO DETERMINE WHETHER THI
|
EXONE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF THE EXONE COMPANY - XONE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-12 18:03:00
| null |
MILWAUKEE, AUG. 12, 2021 /PRNEWSWIRE/ -- ADEMI LLP IS INVESTIGATING EXONE (NASDAQ: XONE), FOR POSSIBLE BREACHES OF FIDUCIARY DUTY AND OTHER VIOLATIONS OF LAW IN ITS TRANSACTION WITH DESKTOP METAL. CLICK HERE TO LEARN HOW TO JOIN THE ACTION: HTTPS://WWW.ADEMILAW.COM/CASE/EXONE-COMPANY OR CALL GURI ADEMI TOLL-FREE AT 866-264-3995.
|
SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER THE EXONE COMPANY HAS OBTAINED A FAIR PRICE IN ITS TRANSACTION WITH DESKTOP METAL, INC.
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-12 16:21:00
| null |
NEW YORK, AUG. 12, 2021 /PRNEWSWIRE/ -- ROWLEY LAW PLLC IS INVESTIGATING POTENTIAL SECURITIES LAW VIOLATIONS BY THE EXONE COMPANY (NASDAQ: XONE) AND ITS BOARD OF DIRECTORS CONCERNING THE PROPOSED ACQUISITION OF THE COMPANY BY DESKTOP METAL, INC. (NYSE: DM). STOCKHOLDERS WILL RECEIVE $8.50 IN CASH AND $17.00 IN SHARES OF DESKTOP METAL COMMON STOCK FOR EACH SHARE OF THE EXONE COMPANY STOCK THAT THEY HOLD.
|
ALERT: ROWLEY LAW PLLC IS INVESTIGATING PROPOSED ACQUISITION OF THE EXONE COMPANY
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-11 19:30:00
| null |
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLP, A GLOBAL INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER THE SALE OF THE EXONE COMPANY (NASDAQ: XONE) TO DESKTOP METAL, INC. IS FAIR TO EXONE SHAREHOLDERS. UNDER THE TERMS OF THE AGREEMENT, EXONE SHAREHOLDERS WILL RECEIVE $8.50 IN CASH AND $17.00 IN SHARES OF DESKTOP METAL COMMON STOCK FOR EACH SHARE OF EXONE COMMON STOCK. HALPER SADEH ENCOURAGES EXONE SHAREHOLDERS TO CLICK HERE TO LEARN MORE ABOUT THEIR LEGAL RIGHTS AND OPTIONS OR CONTACT DANIEL
|
XONE MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF THE EXONE COMPANY IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM – XONE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-11 16:22:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE) (“EXONE” OR THE “COMPANY”), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2021. EXONE WILL NOT HOST A CONFERENCE CALL TO DISCUSS ITS RESULTS FOR THE SECOND QUARTER OF 2021 OR PROVIDE FORWARD GUIDANCE, DUE TO THE ANNOUNCED PROPOSED ACQUISITION OF EXONE BY DESKTOP METAL, INC (“DESKTOP METAL”). INFORMATION RELA
|
THE EXONE COMPANY REPORTS SECOND QUARTER 2021 RESULTS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-11 16:20:00
| null |
BOSTON & NORTH HUNTINGDON, PA.--(BUSINESS WIRE)-- #3DP--DESKTOP METAL ANNOUNCES IT HAS ENTERED INTO A DEFINITIVE AGREEMENT TO ACQUIRE EXONE, CEMENTING ITS LEADERSHIP IN AM FOR MASS PRODUCTION.
|
DESKTOP METAL TO ACQUIRE EXONE, CEMENTING ITS LEADERSHIP IN ADDITIVE MANUFACTURING FOR MASS PRODUCTION
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-08 04:00:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE LAUNCH OF EXONE'S METAL 3D PRINTING ADOPTION CENTER IS DRIVEN BY INCREASED INTEREST BY EUROPEAN MANUFACTURERS IN METAL BINDER JET 3D PRINTING.
|
EXONE OPENS STATE-OF-THE-ART METAL 3D PRINTING ADOPTION CENTER IN EUROPE, EXPANDS ENGINEERING SUPPORT
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-16 09:19:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--ADOPTION CENTER RUNS 24-7 WITH 28 METAL 3D PRINTERS. TWO X1 25PRO SYSTEMS NOW DEDICATED TO STAINLESS STEEL PARTS. X1 METAL 420I™ REMAINS A TOP-SELLER.
|
EXONE METAL 3D PRINTING ADOPTION CENTER SURPASSES 2 MILLION PARTS, ADDS NEW SYSTEMS FOR STAINLESS STEEL PART PRODUCTION
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-26 16:10:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, ANNOUNCED TODAY THAT JOHN HARTNER, CHIEF EXECUTIVE OFFICER, AND DOUG ZEMBA, CHIEF FINANCIAL OFFICER AND TREASURER, WILL PRESENT IN A FIRESIDE CHAT FORMAT AND PARTICIPATE IN ONE-ON-ONE MEETINGS AT THE STIFEL 2021 CROSS SECTOR INSIGHT CONFERENCE ON WEDNESDAY, JUNE 9, 2021. EXONE'S FIRESIDE CHAT WILL BEGIN AT 1:20 P.M. EASTERN TIME. A
|
THE EXONE COMPANY TO PARTICIPATE AT THE STIFEL 2021 CROSS SECTOR INSIGHT CONFERENCE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-17 16:05:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE) (“EXONE” OR THE “COMPANY”), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2021. “THE EXONE TEAM IS PLEASED TO REPORT RECORD LEVELS OF BOTH RECURRING REVENUE AND MACHINE ORDER BACKLOG, WHICH SHOWS THE STRENGTH OF OUR PRODUCT OFFERINGS, ADOPTION MODEL, AND MOMENTUM,” SAID JOHN HARTNER, EXONE'S CEO. “WHILE OUR
|
THE EXONE COMPANY REPORTS FIRST QUARTER 2021 RESULTS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-13 00:01:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--EXONE HAS NOW DOUBLED ITS REPRESENTATION IN GREATER CHINA OVER THE PAST YEAR, BRINGING THE TOTAL NUMBER OF SALES PARTNERS IN THE APAC REGION TO 12.
|
EXONE ADDS TWO NEW PARTNERS IN ASIA THROUGH COLLABORATION WITH AURORA GROUP
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-04 08:45:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)-- #METAL3DPRINTING--CATI, TRIMECH, JAVELIN, AND PURPLE PLATYPUS WILL OFFER EXONE ENTRY-LEVEL METAL 3D PRINTERS, SERVICES, EQUIPMENT AND CONSUMABLES ACROSS 60+ OFFICES.
|
EXONE ADDS FOUR NEW EXPERIENCED 3D SALES PARTNERS TO U.S. AND CANADIAN CHANNEL
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-28 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)-- #3DPRINTING--EXONE NOW OFFERS FAST, DURABLE, AND AFFORDABLE AMCLAD® TOOLING, WHICH LEVERAGES ITS SAND 3D PRINTING TECHNOLOGY FOR A RANGE OF TOOLING APPLICATIONS.
|
EXONE ACCELERATES EXPANSION INTO 3D PRINTED TOOLING BUSINESS WITH ACQUISITION OF FRESHMADE 3D ASSETS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-18 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE WORLD'S LARGEST METAL 3D PRINTER, THE X1 160PRO™, WILL OFFER AN INERT ATMOSPHERE, ENABLING ALUMINUM AND TITANIUM PRODUCTION, IN LATE 2022.
|
EXONE TO OFFER WORLD'S LARGEST METAL BINDER JET 3D PRINTER WITH A CONTROLLED ATMOSPHERE, CAPABLE OF ALUMINUM AND TITANIUM PRODUCTION, IN 2022
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-11 16:33:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--EXONE HAS QUALIFIED 6061 ALUMINUM FOR BINDER JET 3D PRINTING IN A NEW PATENT-PENDING PROCESS WITH FORD MOTOR CO. EXONE NOW OFFERS 23 MATERIALS.
|
EXONE ANNOUNCES ALUMINUM 6061 HAS ACHIEVED ITS CUSTOMER-QUALIFIED STATUS IN COLLABORATION WITH GLOBAL AUTOMAKER
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-08 00:01:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--EXONE ADDS USC SOLUTIONS TO SALES NETWORK SERVING SINGAPORE, MALAYSIA, AND INDONESIA - PART OF EXONE'S AGGRESSIVE GROWTH STRATEGY IN ASIA.
|
EXONE ADDS USC SOLUTIONS TO SALES NETWORK TO SUPPORT GROWTH IN SINGAPORE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-22 00:01:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--EXONE BROADENS SALES NETWORK IN ASIA WITH NEW SOUTH KOREAN SALES PARTNER AND LEADING FOUNDRY SUPPLIER, ABC CORPORATION. AUTOMOTIVE TO BE KEY FOCUS.
|
EXONE ADDS ABC CORPORATION AS 3D PRINTER SALES PARTNER IN SOUTH KOREA
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-10 08:15:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY ANNOUNCED THE PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 1,666,667 SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING PRICE OF $54.00 PER SHARE. THE GROSS PROCEEDS OF THE OFFERING TO THE COMPANY ARE EXPECTED TO BE APPROXIMATELY $90.0 MILLION, BEFORE DEDUCTING THE UNDERWRITING DISCOUNTS AND COMMISSIONS AND OTHER ESTIMATED OFFE
|
EXONE ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-09 16:01:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY ANNOUNCED THAT IT INTENDS TO OFFER AND SELL, SUBJECT TO MARKET CONDITIONS, SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING. ALL OF THE SHARES OF COMMON STOCK TO BE SOLD IN THE OFFERING WILL BE OFFERED BY EXONE. THE OFFERING IS SUBJECT TO MARKET AND OTHER CONDITIONS, AND THERE CAN BE NO ASSURANCE AS TO WHETHER OR
|
EXONE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-08 08:30:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL METAL AND SAND 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY ANNOUNCED THE LAUNCH OF AN ALL-NEW METAL 3D PRINTING SYSTEM THROUGH A STRATEGIC PARTNERSHIP WITH RAPIDIA THAT ENHANCES THE COMPANY'S PORTFOLIO AND TECHNICAL CAPABILITIES, AS WELL AS CERTAIN PRELIMINARY FINANCIAL RESULTS FOR THE FOURTH QUARTER OF 2020 AND FULL YEAR 2021 GUIDANCE. THE NEW EXONE METAL DESIGNLAB™ PRINTER AND X1F
|
EXONE ANNOUNCES STRATEGIC PARTNERSHIP, PRELIMINARY FOURTH QUARTER 2020 FINANCIAL RESULTS AND 2021 OUTLOOK
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-05 16:10:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, ANNOUNCED TODAY THAT JOHN HARTNER, CHIEF EXECUTIVE OFFICER, AND DOUG ZEMBA, CHIEF FINANCIAL OFFICER AND TREASURER, WILL PRESENT AT THE 23RD ANNUAL NEEDHAM GROWTH CONFERENCE ON TUESDAY, JANUARY 12, 2021. EXONE'S PRESENTATION WILL BEGIN AT 8:30 A.M. EASTERN TIME. A LIVE AUDIO WEBCAST OF THE EVENT WILL BE AVAILABLE AT WWW.EXONE.COM. A
|
THE EXONE COMPANY TO VIRTUALLY PRESENT AT THE 23RD ANNUAL NEEDHAM GROWTH CONFERENCE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-05 16:10:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE) (“EXONE” OR THE “COMPANY”), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2020. “EXONE'S GLOBAL TEAM DELIVERED A SOLID QUARTERLY PERFORMANCE, INCLUDING RECORD THIRD QUARTER REVENUE, DESPITE CHALLENGING MARKET CONDITIONS AS A RESULT OF COVID-19,” SAID JOHN HARTNER, EXONE'S CEO. “THROUGHOUT THE QUARTER, WE
|
THE EXONE COMPANY REPORTS 2020 THIRD QUARTER RESULTS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-10-29 08:57:00
| null |
NORTH HUNTINGDON, PA.--(BUSINESS WIRE)--THE EXONE COMPANY (NASDAQ: XONE), THE GLOBAL LEADER IN INDUSTRIAL SAND AND METAL 3D PRINTERS USING BINDER JETTING TECHNOLOGY, TODAY ANNOUNCED AN AGREEMENT TO OPTIMIZE ITS SAND 3D PRINTERS FOR USE WITH PREMIUM NAIGAI CERABEADS® FROM ITOCHU CERATECH CORPORATION, A LEADING JAPANESE CERAMIC PRODUCT MANUFACTURER. CERABEADS® ARE A PREMIUM CERAMIC FOUNDRY SAND USED TO CREATE MOLDS AND CORES FOR METAL CASTING HIGH-VALUE PRODUCTS IN THE AUTOMOTIVE, OIL & GAS,
|
EXONE TO OPTIMIZE SAND 3D PRINTERS FOR USE WITH ITOCHU CERATECH CORPORATION'S CERABEADS®
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-06 18:30:00
| null |
THE EXONE COMPANY REPORTS 2020 SECOND QUARTER RESULTS.Q2 LOSS PER SHARE $0.24.Q2 REVENUE ROSE 3 PERCENT TO $11.1 MILLION.Q2 REVENUE ESTIMATE $7.6 MILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE ESTIMATE $-0.30 -- REFINITIV IBES DATA.EXONE - EXPECT BACKLOG, RECURRING REVENUE STREAM, ACCELERATION IN ADOPTION OF TECHNOLOGY TO PROVIDE BASIS FOR OPERATING STABILITY FOR 2020, INTO 2021.
|
EXONE REPORTS Q2 LOSS PER SHARE OF $0.24
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-07 20:30:00
| null |
THE EXONE COMPANY REPORTS 2020 FIRST QUARTER RESULTS.Q1 LOSS PER SHARE $0.22.Q1 REVENUE $13.4 MILLION VERSUS REFINITIV IBES ESTIMATE OF $11.7 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.27 -- REFINITIV IBES DATA.QUARTER-END BACKLOG OF $33.8 MILLION.FOR REST OF 2020, COMPANY EXPECTS ADDITIONAL CASH CAPITAL EXPENDITURES BETWEEN $1 MILLION AND $2 MILLION.
|
EXONE COMPANY POSTS QUARTERLY LOSS PER SHARE OF $0.22
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-03 19:30:00
| null |
EXONE CO - IN LIGHT OF CHALLENGES CAUSED BY COVID-19 PANDEMIC, ON MARCH 30, CO'S BOARD OF DETERMINED TO REDUCE BY 20% SALARIES OF ITS LEADERSHIP TEAM.EXONE CO - LEADERSHIP TEAM INCLUDING CO'S NAMED EXECUTIVE OFFICERS, REDUCING SALARIES FOR AT LEAST Q2 2020 - SEC FILING.EXONE CO - EXPECTS TO AMEND EMPLOYMENT AGREEMENT FOR JOHN F. HARTNER, CO'S CEO, EFFECTIVE AS OF APRIL 6, 2020, TO REFLECT THIS SALARY REDUCTION.EXONE CO - ON MARCH 30, BOARD ALSO DETERMINED TO REDUCE BY 20% THE CASH PORTION OF THEIR DIRECTOR FEES FOR AT LEAST Q2 2020.
|
EXONE DETERMINED TO REDUCE BY 20% SALARIES OF ITS LEADERSHIP TEAM
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-12 19:30:00
| null |
THE EXONE COMPANY REPORTS 2019 FOURTH QUARTER RESULTS.Q4 LOSS PER SHARE $0.12.Q4 REVENUE $17.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $21.2 MILLION.Q4 EARNINGS PER SHARE ESTIMATE $-0.00 -- REFINITIV IBES DATA.Q4 REVENUE SHORTFALL WAS LARGELY ASSOCIATED WITH TIMING & DURATION OF NEW MODEL MACHINE INSTALLATIONS.
|
THE EXONE COMPANY REPORTS 2019 FOURTH QUARTER RESULTS
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-18 22:30:00
| null |
THE EXONE COMPANY ANNOUNCED THAT THE PRODUCTION VERSION OF THE X1 25PRO METAL 3D PRINTER, WHICH BEGINS SHIPPING TO CUSTOMERS THIS QUARTER, WILL MAKE ITS GLOBAL DEBUT AT FORMNEXT 2019. WITH BUILD DIMENSIONS OF 400 X 250 X 250 MM (15.75 X 9.84 X 9.84 IN), THE X1 25PRO IS LARGE ENOUGH TO ACCOMMODATE PRODUCTION OF MOST METAL PARTS MANUFACTURED TODAY. THE NEW SYSTEM IS NOW POSITIONED AS THE MID-SIZED MODEL WITHIN EXONE’S GROWING FAMILY OF METAL 3D PRINTERS, WHICH ARE ALSO CAPABLE OF 3D PRINTING CERAMICS. EXONE’S ENTRY-LEVEL INNOVENT PRINTER IS USED GLOBALLY FOR RESEARCH, DESIGN AND SMALL PART PRODUCTION. THE RECENTLY ANNOUNCED X1 160PRO™ BINDER JETTING MACHINE, WITH BUILD DIMENSIONS OF 800 X 500 X 400 MM (31.5 X 19.7 X 15.8 IN), IS BUILT FOR EXTRA-LARGE PRODUCTION AND IS SLATED TO SHIP IN LATE 2020. THE X1 25PRO IS CAPABLE OF BINDER JETTING A VARIETY OF METAL, CERAMIC AND COMPOSITE FINE POWDERS — PRIMARILY BECAUSE OF EXONE’S EXCLUSIVE AND PATENTED TRIPLE ADVANCED COMPACTION TECHNOLOGY (ACT), WHICH IS CRITICAL TO DELIVERING CONSISTENT PART DENSITY AND REPEATABILITY ACROSS THE ENTIRE BUILD AREA. TO DATE, THE X1 25PRO CAN PRINT MORE THAN SIX METAL MATERIALS THAT HAVE PASSED EXONE’S STRICT QUALIFICATION PROCESS, INCLUDING 316L, 304L AND 17-4PH STAINLESS STEELS. HOWEVER, IT IS ALSO CAPABLE OF PRINTING A VARIETY OF OTHER BETA MATERIALS THAT ARE ON A FAST-TRACK TO QUALIFICATION, INCLUDING INCONEL 718 AND 625 AND MORE. TO EARN QUALIFICATION, A METAL MUST DELIVER REPEATABLE, DESIRABLE PERFORMANCE IN BOTH 3D PRINTING AND SINTERING. THE NEW X1 25PRO FEATURES 18 BODY PANELS THAT WERE VACUUM FORMED OVER UNIQUE 3D PRINTED TOOLING CREATED WITH EXONE TECHNOLOGY.
|
THE EXONE COMPANY DEBUTS PRODUCTION MODEL OF X1 25PRO METAL 3D PRINTER AT FORMNEXT
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-11-11 22:30:00
| null |
THE EXONE COMPANY ANNOUNCED A NEW CLEAN-BURNING METAL BINDER, CLEANFUSE, THAT WILL ENABLE FUTURE BINDER JET 3D PRINTING OF PREMIUM METALS SUCH AS ALUMINUM AND TITANIUM, WHICH ARE SENSITIVE TO CARBON RESIDUE LEFT BEHIND BY OTHER BINDING AGENTS DURING SINTERING. THE PATENT-PENDING FORMULA WILL BE AVAILABLE IN THE FIRST QUARTER OF 2020. WHILE EXONE SYSTEMS ALREADY BINDER JET MORE THAN SIX QUALIFIED METALS, INCLUDING THE POPULAR STAINLESS STEELS 316L, 304LAND 17-4PH, A CLEAN-BURNING BINDER IS A KEY STEP IN THE DEVELOPMENT OF BINDER JET 3D PRINTING FOR SOME OTHER HIGH-DEMAND METALS, AS WELL AS SOME CERAMICS. PRESERVING METAL PERFORMANCE IN BINDER JETTING: BINDER JETTING IS A MATURE 3D PRINTING PROCESS THAT USES A DIGITAL FILE TO QUICKLY INKJET A BINDER INTO A BED OF POWDER PARTICLES — METAL, SAND OR CERAMIC — CREATING A SOLID PART ONE LAYER AT A TIME. WHEN PRINTING METALS, THE FINAL PART MUST BE SINTERED IN ORDER TO FUSE THE PARTICLES TOGETHER INTO A SOLID OBJECT. COMPARED TO OTHER MANUFACTURING METHODS, BINDER JETTING IS A FAST AND LOW-WASTE METHOD OF MAKING PRECISION METAL PARTS AND PRODUCTS. WHAT’S MORE, IT OFFERS NEW DESIGN FREEDOMS NOT PREVIOUSLY POSSIBLE. WHEN BINDERS DON’T BURN OFF CLEANLY DURING SINTERING, HOWEVER, CARBON RESIDUE CAN ALTER THE CHEMISTRY AND FUNDAMENTAL PERFORMANCE OF SOME SENSITIVE METALS. CONSEQUENTLY, A BENEFIT OF 3D PRINTING METALS WITH CLEANFUSE IS PRESERVING CONSISTENT PART PERFORMANCE, INCLUDING A PART’S ABILITY TO BE WELDED. THIS IS CRITICAL FOR AEROSPACE, AUTOMOTIVE OR DEFENSE APPLICATIONS, WHERE PARTS ARE OFTEN INTEGRATED OR ASSEMBLED INTO A FINAL PRODUCT. NEW FUSE LINE OF BINDERS: CLEANFUSE WILL BE PART OF THE NEWLY BRANDED EXONE FUSE LINE OF BINDERS – A CHANGE THAT REFLECTS THE GROWING IMPORTANCE OF EXONE’S BINDER CHEMISTRIES IN DELIVERING EXCEPTIONAL 3D PRINTED CORES, MOLDS, TOOLING, AND FINAL END-USE PARTS. EXONE’S FAMILY OF FUSE BINDERS FOR METAL AND CERAMIC 3D PRINTERS NOW INCLUDES: CLEANFUSE – A PREMIUM, CLEAN-BURNING BINDER THAT LEAVES BEHIND NO CARBON RESIDUE AND WORKS WELL WITH METALLIC MATERIALS NEGATIVELY AFFECTED BY CARBON, SUCH AS ALUMINUM AND TITANIUM; AQUAFUSE – A WATER-BASED BINDER THAT WORKS WELL WITH A VARIETY OF METALLIC MATERIALS; FLUIDFUSE – A VERSATILE SOLVENT-BASED BINDER WITH LOW VISCOSITY THAT WORKS WELL WITH A VARIETY OF METALLIC AND NON-METALLIC MATERIALS, INCLUDING CERAMICS; AND PHENOLFUSE – A PHENOLIC BINDER BEST SUITED FOR PRINTING HIGH-TEMPERATURE MATERIALS, INCLUDING NON-METALLICS SUCH AS CARBON, TUNGSTEN CARBIDE (WC), SILICON CARBIDE (SIC), AND OTHER CERAMICS.
|
THE EXONE COMPANY LAUNCHES NEW CLEAN-BURNING METAL BINDER, CLEANFUSE
|
XONE
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.